Condensed Statement of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses
Research and development	$ 13,894	$ 9,880	$ 37,420	$ 23,101
General and administrative	4,368	3,196	12,159	7,292
Total operating expenses	18,262	13,076	49,579	30,393
Loss from operations	(18,262)	(13,076)	(49,579)	(30,393)
Other income
Interest income	764	127	1,354	276
Total other income	764	127	1,354	276
Net loss	(17,498)	(12,949)	(48,225)	(30,117)
Other comprehensive income (loss):
Unrealized gain (loss) on available-for-sale securities	157	9	(1,665)	(24)
Total comprehensive loss	$ (17,341)	$ (12,940)	$ (49,890)	$ (30,141)
Net loss per share, basic (in dollars per share)	$ (0.34)	$ (0.26)	$ (0.96)	$ (0.90)
Net loss per share, diluted (in dollars per share)	$ (0.34)	$ (0.26)	$ (0.96)	$ (0.90)
Weighted-average shares outstanding, basic	51,844,904	49,264,938	50,345,841	33,535,829
Weighted-average shares outstanding, diluted	51,844,904	49,264,938	50,345,841	33,535,829